K200279 is an FDA 510(k) clearance for the ImmunoCAP Allergen o215, Component nGal-alpha-1,3-Gal(alpha-Gal) Thyroglobulin, bovine. This device is classified as a System, Test, Radioallergosorbent (rast) Immunological (Class II - Special Controls, product code DHB).
Submitted by Phadia AB (Uppsala, SE). The FDA issued a Cleared decision on May 1, 2020, 87 days after receiving the submission on February 4, 2020.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5750.